A closed Ir4 carbonyl cluster, 1, comprising a tetrahedral metal frame and three tert-butyl-calix[4]arene(OPr)3(OCH2PPh2) (Ph = phenyl; Pr = propyl) ligands at the basal plane, was silica supported and consists of “*” and “S” sites, which could be dialed in selectively for controlling ethylene hydrogenation catalysis.
Although essentially molecular noble metal species provide active sites and highly tunable platforms for the design of supported catalysts, the susceptibility of the metals to reduction and aggregation and the consequent loss of catalytic activity and selectivity limit opportunities for their application. Here, we demonstrate a new construct to stabilize supported molecular noble-metal catalysts, taking advantage of sterically bulky ligands on the metal that serve as surrogate supports and isolate the active sites under conditions involving steady-state catalytic turnover in a reducing environment. The result is demonstrated with an iridium pair-site catalyst incorporating P-bridging calix[4]arene ligands dispersed on siliceous supports, chosen as prototypes because they offer weakly interacting surfaces on which metal aggregation is prone to occur. This catalyst was used for the hydrogenation of ethylene in a flow reactor. Atomic-resolution imaging of the Ir centers and spectra of the catalyst before and after use show that the metals resisted aggregation and deactivation, remaining atomically dispersed and accessible for catalysis. This strategy thus allows the stabilization of the catalysts even when they are weakly anchored to supports.
A substituted tetrairidium carbonyl cluster on a silica support undergoes hydrogen activation at a rate and with a mechanism different from the cluster in solution.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.